(Q37058001)

18 August 2017

1 reference

title

Treatment options for multidrug-resistant Acinetobacter species (English)

1 reference

18 August 2017

main subject

multiple drug resistance

1 reference

1

Jacob Gilad

1 reference

18 August 2017

Yehuda Carmeli

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

68

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

165-189

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200868020-00003

18 August 2017

exact match

0 references

cites work

Cell phones and Acinetobacter transmission

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Nosocomial Acinetobacter meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00003

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

21 January 2018

1 reference

12 December 2020

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

1 reference

12 December 2020

Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis

1 reference

12 December 2020

Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains

1 reference

12 December 2020

AcinetobacterOutbreaks, 1977–2000

1 reference

12 December 2020

Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E.

1 reference

12 December 2020

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii

1 reference

12 December 2020

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

1 reference

12 December 2020

Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic.

1 reference

12 December 2020

Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians

1 reference

12 December 2020

Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

1 reference

12 December 2020

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

1 reference

12 December 2020

Novel therapies of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter spp. infections: the state of the art.

1 reference

12 December 2020

Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology

1 reference

12 December 2020

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

1 reference

12 December 2020

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

1 reference

12 December 2020

Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium

1 reference

12 December 2020

Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii

1 reference

12 December 2020

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

1 reference

12 December 2020

Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.

1 reference

12 December 2020

Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones

1 reference

12 December 2020

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

1 reference

12 December 2020

The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance

1 reference

12 December 2020

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii

1 reference

12 December 2020

Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates

1 reference

12 December 2020

Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin

1 reference

12 December 2020

Multidrug resistance to antimicrobials as a predominant factor influencing patient survival

1 reference

12 December 2020

Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features

1 reference

12 December 2020

Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays

1 reference

12 December 2020

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

1 reference

12 December 2020

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world

1 reference

12 December 2020

Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

1 reference

12 December 2020

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

1 reference

12 December 2020

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

1 reference

12 December 2020

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

1 reference

12 December 2020

In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak

1 reference

12 December 2020

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

12 December 2020

Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam

1 reference

12 December 2020

Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates

1 reference

12 December 2020

In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.

1 reference

12 December 2020

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

1 reference

12 December 2020

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).

1 reference

12 December 2020

Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii

1 reference

12 December 2020

Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations

1 reference

12 December 2020

Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting.

1 reference

12 December 2020

Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

1 reference

12 December 2020

"All-in-one-plate" E-test and disk diffusion susceptibility co-testing for multiresistant Acinetobacter baumannii.

1 reference

12 December 2020

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain

1 reference

12 December 2020

Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin

1 reference

12 December 2020

Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients

1 reference

12 December 2020

Predictors of mortality in Acinetobacter baumannii bacteremia.

1 reference

12 December 2020

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

12 December 2020

In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates

1 reference

12 December 2020

In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe

1 reference

12 December 2020

Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline

1 reference

12 December 2020

Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with bla(TEM-1), AmpC-type bla and integrase 1 genotypes

1 reference

12 December 2020

Comparative genomics of multidrug resistance in Acinetobacter baumannii

1 reference

12 December 2020

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

1 reference

12 December 2020

Amikacin and colistin for treatment of Acinetobacter baumannii meningitis

1 reference

12 December 2020

Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

1 reference

12 December 2020

Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.

1 reference

12 December 2020

Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii

1 reference

12 December 2020

In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.

1 reference

12 December 2020

Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains

1 reference

12 December 2020

A new screening method for carbapenem-resistant Acinetobacter baumanii and Pseudomonas aeruginosa.

1 reference

12 December 2020

Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

1 reference

12 December 2020

Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002.

1 reference

12 December 2020

Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.

1 reference

12 December 2020

Treatment options for multidrug-resistant bacteria.

1 reference

12 December 2020

In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan

1 reference

12 December 2020

Using intrathecal colistin for multidrug resistant shunt infection

1 reference

12 December 2020

Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis

1 reference

12 December 2020

Tigecycline: clinical evidence and formulary positioning

1 reference

12 December 2020

The epidemiology and control of Acinetobacter baumannii in health care facilities

1 reference

12 December 2020

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

1 reference

12 December 2020

Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU

1 reference

12 December 2020

Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?

1 reference

12 December 2020

Intrathecal use of colistin.

1 reference

12 December 2020

Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

1 reference

12 December 2020

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin

1 reference

12 December 2020

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

12 December 2020

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy

1 reference

12 December 2020

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

1 reference

12 December 2020

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

1 reference

12 December 2020

Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.

1 reference

12 December 2020

Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii

1 reference

12 December 2020

Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii

1 reference

12 December 2020

Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains

1 reference

12 December 2020

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem

1 reference

12 December 2020

In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals

1 reference

12 December 2020

Discordance of meropenem versus imipenem activity against Acinetobacter baumannii

1 reference

12 December 2020

Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia

1 reference

12 December 2020

Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa

1 reference

12 December 2020

Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin

1 reference

12 December 2020

AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains

1 reference

12 December 2020

Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility

1 reference

12 December 2020

Exceptional desiccation tolerance of Acinetobacter radioresistens.

1 reference

12 December 2020

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa

1 reference

12 December 2020

Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.

1 reference

12 December 2020

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii

1 reference

12 December 2020

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

1 reference

12 December 2020

Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.

1 reference

12 December 2020

Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action

1 reference

12 December 2020

Comparison of methods of interpretation of checkerboard synergy testing

1 reference

12 December 2020

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

1 reference

12 December 2020

In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model

1 reference

12 December 2020

Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii

1 reference

12 December 2020

In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

1 reference

12 December 2020

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

1 reference

12 December 2020

Cerebrospinal meningitis with the presence of Acinetobacter spp

1 reference

12 December 2020

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

1 reference

12 December 2020

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

12 December 2020

In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii.

1 reference

12 December 2020

Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species

1 reference

12 December 2020

Heteroresistance to carbapenems in Acinetobacter baumannii

1 reference

12 December 2020

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

1 reference

12 December 2020

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

1 reference

12 December 2020

Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia

1 reference

12 December 2020

In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii.

1 reference

12 December 2020

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

1 reference

12 December 2020

Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test.

1 reference

12 December 2020

EUCAST technical note on tigecycline

1 reference

12 December 2020

Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro

1 reference

12 December 2020

Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report.

1 reference

12 December 2020

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

1 reference

12 December 2020

Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii

1 reference

12 December 2020

Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

1 reference

12 December 2020

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii

1 reference

12 December 2020

Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin

1 reference

12 December 2020

Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii.

1 reference

12 December 2020

In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.

1 reference

12 December 2020

Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents

1 reference

12 December 2020

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

1 reference

12 December 2020

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

12 December 2020

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

12 December 2020

Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study

1 reference

12 December 2020

Antimicrobial resistance of Acinetobacter spp. in Europe

1 reference

12 December 2020

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

1 reference

12 December 2020

Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals

1 reference

12 December 2020

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

1 reference

12 December 2020

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

1 reference

12 December 2020

Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin

1 reference

12 December 2020

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

1 reference

12 December 2020

In vitro activity of ertapenem: review of recent studies

1 reference

12 December 2020

Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan

1 reference

12 December 2020

Tigecycline: a novel glycylcycline antibiotic

1 reference

12 December 2020

Persistent Acinetobacter baumannii? Look inside your medical equipment

1 reference

12 December 2020

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

12 December 2020

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

1 reference

12 December 2020

Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system

1 reference

12 December 2020

Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit?

1 reference

12 December 2020

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

12 December 2020

Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

1 reference

12 December 2020

Use of intravenous polymyxin B during continuous venovenous hemodialysis.

1 reference

12 December 2020

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

1 reference

12 December 2020

Metallo-beta-lactamases: the quiet before the storm?

1 reference

12 December 2020

Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia.

1 reference

12 December 2020

Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections

1 reference

12 December 2020

In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin

1 reference

12 December 2020

In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.

1 reference

12 December 2020

The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes

1 reference

12 December 2020

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

1 reference

12 December 2020

Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory

1 reference

12 December 2020

Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients.

1 reference

12 December 2020

Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals

1 reference

12 December 2020

Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals

1 reference

12 December 2020

10.2165/00003495-200868020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1039124181

0 references

1 reference